rs121908544
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000334.4(SCN4A):c.4342C>T(p.Arg1448Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000689 in 1,451,852 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1448G) has been classified as Pathogenic.
Frequency
Consequence
NM_000334.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN4A | NM_000334.4 | c.4342C>T | p.Arg1448Cys | missense_variant | 24/24 | ENST00000435607.3 | NP_000325.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN4A | ENST00000435607.3 | c.4342C>T | p.Arg1448Cys | missense_variant | 24/24 | 1 | NM_000334.4 | ENSP00000396320.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome AF: 6.89e-7 AC: 1AN: 1451852Hom.: 0 Cov.: 35 AF XY: 0.00 AC XY: 0AN XY: 720508
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not provided Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2022 | SCN4A: PP1:Strong, PM1, PM2, PM5, PS4:Moderate, PP3, PP4 - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Sep 20, 2021 | Reported in the heterozygous state in multiple unrelated families with paramyotonia congenita (Ptacek et al., 1992; Meyer-Kleine et al., 1994); Functional studies indicated that R1448C impacts the channel inactivation in vitro (Chahine et al., 1994; Yang et al., 1994); Not observed at significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 16801039, 8005599, 18166706, 21490317, 26036855, 23417379, 27199537, 12483017, 12552059, 7809121, 30028520, 30930557, 31544778, 32849172, 26484179, 20301669, 32660787, 1316765, 8110459) - |
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Apr 06, 2016 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jun 16, 2023 | This variant has been identified in multiple individuals with paramyotonia congenita and has been shown to associate with paramyotonia congenita in multiple families. This variant has not been reported in large, multi-ethnic general populations (http://gnomad.broadinstitute.org). At least one other missense variant at this codon is considered to be pathogenic or likely pathogenic, suggesting this variant may also cause disease. Assessment of experimental evidence suggests this variant results in abnormal protein function. Cells expressing this variant showed slower current inactivation, faster recovery from inactivation and increased persistent current when compared to WT (PMID: 7809121, 8833340, 21317558). The variant is located in a region that is considered important for protein function and/or structure. - |
Hyperkalemic periodic paralysis Pathogenic:1Other:1
not provided, no classification provided | literature only | GeneReviews | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 09, 2024 | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 1448 of the SCN4A protein (p.Arg1448Cys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with paramyotonia congenita (PMID: 1316765, 8005599, 16801039). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 5898). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SCN4A protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects SCN4A function (PMID: 7809121, 8110459, 21490317). This variant disrupts the p.Arg1448 amino acid residue in SCN4A. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 1316765, 8005599, 8110459). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. - |
Hypokalemic periodic paralysis, type 2 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics | Apr 01, 2024 | A heterozygous missense variant in exon 24 of the SCN4A gene that results in the amino acid substitution of Cysteine for Arginine at codon 1448 (p.Arg1448Cys) was detected. The observed variant has previously been reported in patients in affected with SCN4A related conditions [PMID:16801039]. The variant has not been reported in the 1000 genomes, gnomAD (v3.1), gnomdAD (v2.1) and topmed databases. The in-silico prediction of the variant are damaging by PolyPhen-2 (HumDiv), SIFT, LRT and MutationTaster2. The reference codon is conserved across species. In summary, the variant meets our criteria to be classified as pathogenic. - |
Paramyotonia congenita of Von Eulenburg Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | May 01, 1992 | - - |
Hypokalemic periodic paralysis, type 1 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | DASA | Jan 05, 2022 | The c.4342C>T;p.(Arg1448Cys) missense variant has been observed in affected individual(s) and ClinVar contains an entry for this variant (Clinvar ID: 5898; PMID: 12483017; 12552059; 16801039; 18033047; 21490317; 26484179; 27199537; 26036855; 30028520) - PS4.This variant is not present in population databases (rs121908544, gnomAD; ABraOM no frequency - http://abraom.ib.usp.br/) - PM2. Pathogenic missense variant in this residue have been reported (Clinvar ID: 5899; 221263; 221262) - PM5. The variant co-segregated with disease in multiple affected family members (PMID: 12483017; 16801039; 18033047; 26484179) - PP1_strong. In summary, the currently available evidence indicates that the variant is pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at